T. Rowe Price Investment Management, Inc. Outset Medical, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.07 - $10.25 $2,293 - $7,656	-747 Reduced 0.02%	3,166,747 $17.1 Million
Q2 2023 Aug 14, 2023	SELL	$17.18 - $23.76 $2.18 Million - $3.01 Million	-126,654 Reduced 3.84%	3,167,494 $69.3 Million
Q1 2023 May 15, 2023	SELL	$18.25 - $30.26 $4.12 Million - $6.83 Million	-225,722 Reduced 6.41%	3,294,148 $60.6 Million
Q4 2022 Feb 14, 2023	BUY	$12.36 - $26.41 $4.29 Million - $9.16 Million	346,744 Added 10.93%	3,519,870 $90.9 Million
Q3 2022 Nov 14, 2022	BUY	$14.67 - $21.7 $46.5 Million - $68.9 Million	3,173,126 New	3,173,126 $50.5 Million

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $185M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.